These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5398475)

  • 21. [The dipyridamol test and coronary heart disease].
    Grosse-Heitmeyer W; Görtz P; Drüke P; Mönninghoff W; Most E; St Müller US; Bender F
    Med Welt; 1982 Jul; 33(26):960-1. PubMed ID: 7109954
    [No Abstract]   [Full Text] [Related]  

  • 22. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary therapy using Angitrit].
    Kortun RC
    Med Welt; 1975 Sep; 26(37):1983-7. PubMed ID: 1100991
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical electrocardiographic assessment of the state of the coronary circulation at different periods before the occurrence of myocardial infarct].
    Isakhanian GS
    Vrach Delo; 1980 Apr; (4):35-8. PubMed ID: 7385769
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of syncoumar on the status of the coagulating and anticoagulating systems of the blood in patients with myocardial infarct and chronic coronary insufficiency].
    Orlova NP
    Ter Arkh; 1966 Apr; 38(4):43-7. PubMed ID: 5984661
    [No Abstract]   [Full Text] [Related]  

  • 28. [Administration of synanthrin in therapy of coronary atherosclerosis].
    Zolotarev AE
    Fiziol Zh; 1970; 16(5):685-6. PubMed ID: 5507977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of myocardial risk on basis of the outcome of previous myocardial infarcts. Advantages of myocardial tomoscintigraphy using thallium with dipyridamole].
    Baroffio R; Palagi B
    Minerva Cardioangiol; 1993 Sep; 41(9):337-42. PubMed ID: 8259229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrocardiographic telemetry in rehabilitation of patients with acute myocardial infarct and severe coronary insufficiency].
    Angellino PF; Severgnini B; De Benedictis N; Belli C
    Boll Soc Ital Cardiol; 1971; 16(9):559-69. PubMed ID: 5150380
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dipyramidole in the therapy of acute coronary syndromes].
    Novelli E; Cecchi A
    Minerva Cardioangiol; 1972 Apr; 20(4):179-216. PubMed ID: 5023725
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of intensain on electrocardiographic and clinical manifestations of acute coronary insufficiency].
    Chamla J
    Sem Ther; 1968; 44(6):405-6. PubMed ID: 5684107
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnosis and pharmacotherapy of the microcirculatory disorders in myocardial infarct].
    Kononeko LG
    Vrach Delo; 1978 Aug; (8):73-8. PubMed ID: 695511
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myocardial infarct as a stochastic manifestation].
    Drdková S; Zaloudek M
    Cesk Zdrav; 1969; 17(10):437-9. PubMed ID: 5343835
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical trial of the Cardiocap R capsule with prolonged action in myocardial infarct and coronary insufficiency].
    Sarnari V; Garassini G
    Minerva Cardioangiol; 1973 Nov; 21(11):732-7. PubMed ID: 4776568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombodensitographic changes during treatment with a coumarin derivative].
    Ferri F; Regazzini A
    Minerva Med; 1970 Jan; 61(8):309-18. PubMed ID: 4189912
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electrocardiographic evolution of cardiac infarct in patients treated with sodium 3,4,5-trimethoxybenzoyl-epsilon-aminocaproate].
    Pittera A; Di Blasi F; Ruvolo F; Midili N; Gramolini C
    Minerva Cardioangiol; 1975 Sep; 23(9):527-60. PubMed ID: 1161165
    [No Abstract]   [Full Text] [Related]  

  • 38. [The efficacity of adenosine triphosphoric acid in the treatment of patients with coronary cardiosclerosis].
    Belen'kiĭ AI
    Klin Med (Mosk); 1969 Feb; 47(2):61-7. PubMed ID: 5379262
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical considerations on the use of hydrocortisone in the treatment of myocardial infarct].
    Cristiano P; Persico E; Cantafio S; Leotta A; Giraldi A
    Minerva Cardioangiol; 1974 Dec; 22(12):840-51. PubMed ID: 4459728
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy].
    Dewar HA
    Minerva Med; 1971 Sep; 62(72):3456-7. PubMed ID: 5097216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.